These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells. Gürlevik E; Fleischmann-Mundt B; Brooks J; Demir IE; Steiger K; Ribback S; Yevsa T; Woller N; Kloos A; Ostroumov D; Armbrecht N; Manns MP; Dombrowski F; Saborowski M; Kleine M; Wirth TC; Oettle H; Ceyhan GO; Esposito I; Calvisi DF; Kubicka S; Kühnel F Gastroenterology; 2016 Aug; 151(2):338-350.e7. PubMed ID: 27210037 [TBL] [Abstract][Full Text] [Related]
6. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796 [TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix. Okumura T; Ohuchida K; Kibe S; Iwamoto C; Ando Y; Takesue S; Nakayama H; Abe T; Endo S; Koikawa K; Sada M; Horioka K; Mochidome N; Arita M; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M Int J Cancer; 2019 Mar; 144(6):1401-1413. PubMed ID: 30152542 [TBL] [Abstract][Full Text] [Related]
8. Fatty acids from fat cell lipolysis do not activate an inflammatory response but are stored as triacylglycerols in adipose tissue macrophages. Caspar-Bauguil S; Kolditz CI; Lefort C; Vila I; Mouisel E; Beuzelin D; Tavernier G; Marques MA; Zakaroff-Girard A; Pecher C; Houssier M; Mir L; Nicolas S; Moro C; Langin D Diabetologia; 2015 Nov; 58(11):2627-36. PubMed ID: 26245186 [TBL] [Abstract][Full Text] [Related]
9. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980 [TBL] [Abstract][Full Text] [Related]
10. Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2). Heckmann BL; Zhang X; Xie X; Saarinen A; Lu X; Yang X; Liu J J Biol Chem; 2014 Jan; 289(4):1905-16. PubMed ID: 24302733 [TBL] [Abstract][Full Text] [Related]
11. Modifications induced by dietary lipid source in adipose tissue phospholipid fatty acids and their consequences in lipid mobilization. Portillo MP; Tueros AI; Perona JS; Ruiz-Gutiérrez V; Torres I; Macarulla MT Br J Nutr; 1999 Oct; 82(4):319-27. PubMed ID: 10655981 [TBL] [Abstract][Full Text] [Related]
12. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells. Hong X; Li ZX; Hou J; Zhang HY; Zhang CY; Zhang J; Sun H; Pang LH; Wang T; Deng ZH BMC Cancer; 2021 Jan; 21(1):33. PubMed ID: 33413231 [TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer. Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902 [TBL] [Abstract][Full Text] [Related]
14. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599 [TBL] [Abstract][Full Text] [Related]
15. Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™. Haqq J; Howells LM; Garcea G; Dennison AR Mol Nutr Food Res; 2016 Jun; 60(6):1437-47. PubMed ID: 26603273 [TBL] [Abstract][Full Text] [Related]
16. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. Matsuzawa F; Kamachi H; Mizukami T; Einama T; Kawamata F; Fujii Y; Fukai M; Kobayashi N; Hatanaka Y; Taketomi A BMC Cancer; 2021 Feb; 21(1):200. PubMed ID: 33637083 [TBL] [Abstract][Full Text] [Related]
17. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma. Proctor E; Waghray M; Lee CJ; Heidt DG; Yalamanchili M; Li C; Bednar F; Simeone DM PLoS One; 2013; 8(2):e55820. PubMed ID: 23437065 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028 [TBL] [Abstract][Full Text] [Related]
19. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235 [TBL] [Abstract][Full Text] [Related]
20. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]